Thursday, August 29, 2024
|
|
7:30 a.m. – 8:30 a.m.
|
Non-CME Product Theater Breakfast
|
|
8:30 a.m. – 9:30 a.m.
|
Welcome Announcements and Content From ASCO - Lymphoma
Speaker: Catherine Largent, PA-C, CPAAPA, Physician Assistant, Tennessee Oncology
CME: 0.75
This session will review current ASCO recommendations for the treatment of lymphoma. The overview will include evolving treatment modalities such as immunotherapy, BiTE, and cellular therapy's roles in lymphoma management. The session will also address new data and literature and their limitations on treating lymphoma.
|
|
9:30 a.m. – 10:15 a.m.
|
Content From ASCO - Breast
Speaker: Allison Walker, APRN, AGACNP-BC, Nurse Practitioner, Vanderbilt Breast Center
CME: 0.75
Updates from 2024 ASCO meeting on the treatment of breast cancer.
|
|
10:15 a.m. – 10:40 a.m.
|
Refreshment Break With Exhibitors
|
|
10:45 a.m. – 11:30 a.m.
|
Content From ASCO - Myeloma
Speaker: Dwight Macero, MS, PA-C
CME: 0.75
|
|
11:30 a.m. – 12:15 p.m.
|
Content From ASCO - Genitourinary
CME: 0.75
|
|
12:20 p.m. – 1:20 p.m.
|
Non-CME Product Theater Lunch
Presented by AbbVie
|
|
1:25 p.m. – 2:10 p.m.
|
Content From ASCO - CNS
Speaker: Alisha DeTroye, PA-C, MMS, DFAAPA, Regional Director of Advanced Practice, Atrium Health Wake Forest Baptist-Advocate Health
CME: 0.75
This session will review evidence based medicine updates in the treatment of neuro-oncology patients from ASCO 24. The session will also review ASCO 23 updates on IDH inhibitors in the management of IDH mutant gliomas and application to practice.
|
|
2:10 p.m. – 3:00 p.m.
|
Empowering Women in Cancer Care: Oncofertility Options and Addressing Sexual Dysfunction
Speaker: Karina Nieto, MD, Director of Brachytherapy, University Hospitals Case Western
CME: 0.75
Reproductive options and sexual function are important topics to discuss with patients prior to beginning cancer treatment. We will discuss barriers to addressing these topics and options that we can provide our patients to improve the quality of their care.
|
|
3:00 p.m. – 3:25 p.m.
|
Refreshment Break With Exhibitors
|
|
3:25 p.m. – 4:25 p.m.
|
Panel Discussion - Community Oncology and Academic Medicine
Panelists: Jonathan Mcguirt, PA-C, MPH, Lead APP - Medical Oncology, Novant Health Cancer Institute - Forsyth; Megan Dupuis, MD, PhD, Assistant Professor of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center; Stacey Becker, PA-C, Director Advanced Practice Providers, Endeavor Health
CME: 1.00
Panel discussion focused on identifying best practices and challenges in community based and academic practice settings.
|
|
4:30 p.m. – 4:35 p.m.
|
Closing Announcements
|
|
4:40 p.m. – 5:40 p.m.
|
Lumbar Puncture Workshop - Free to attend, but you must sign up.
Workshop Presenters: Jeremy Heinerich and Dwight Macero
CME: 1.00
|
| 4:40 p.m. – 5:40 p.m. |
Elevating Your Voice! From the Elevator to the Board Room - Free to attend, but you must sign up.
Workshop Presenters: Alisha DeTroye, PA-C, MMS, DFAAPA, Regional Director of Advanced Practice, Atrium Health Wake Forest Baptist-Advocate Health and Risa Zimmerman, PA-C, Director, Office of Advanced Practice, Nebraska Medicine
CME: 1.00
An interactive, fun workshop to help you develop your brand and ease your anxiety with public speaking. Whether it is your next elevator pitch, clinical proposal, or podium presentation, we want it to be a success! This session will review different strategies of public speaking to elevate your voice based on the audience and improve your confidence as you embark on your next presentation through hands on practice in workshop format.
|
|
6:30 p.m. – 9:30 p.m.
|
Welcome Reception at Nashville Underground
Get ready to let loose with bowling, rooftop dancing, mouthwatering Mimi's hot chicken, and BBQ, all surrounded by the incredible company of APAO members!
BACK TO TOP
|
Friday, August 30, 2024
|
|
7:30 a.m. – 8:30 a.m.
|
Non-CME Product Theater Breakfast
Presented by Blueprint Medicines
|
|
8:35 a.m. – 9:45 a.m.
|
Welcome Announcements and Keynote Speaker
CME: 1.00
|
|
9:45 a.m. – 10:15 a.m.
|
Membership/State of APAO
CME: 0.50
|
|
10:15 a.m. – 10:40 a.m.
|
Refreshment Break With Exhibitors
|
|
10:45 a.m. – 11:30 a.m.
|
Content From ASCO - Thoracic Oncology
Speaker: Jonathan Mcguirt, PA-C, MPH, Lead APP - Medical Oncology, Novant Health Cancer Institute - Forsyth
CME: 0.75
This session will explore the most relevant presentations and datasets from ASCO 2024 that pertain to thoracic oncology. We will discuss how these data may affect practice patterns moving forward, and critically examine what is not yet ready for prime time. Particular focus will be given to updates on the use of immunotherapy in the perioperative setting.
|
|
11:30 a.m. – 12:20 p.m.
|
AI Model Predictive of Hormone Therapy Benefit in Men With Prostate Cancer
CME: 0.75
|
|
12:25 p.m. – 1:25 p.m.
|
Non-CME Product Theater Lunch
Presented by Incyte
|
1:30 p.m. – 2:30 p.m.
|
Networking Session: Pathways to Progress: Career Advancement in Oncology Care
Speakers: Cory Edgar, DMSc, PA-C, Associate Professor/Academic Director, AdventHealth University, more speaker information coming soon.
CME: 1.00
|
|
2:30 p.m. – 2:45 p.m.
|
Refreshment Break With Exhibitors
|
|
2:45 p.m. – 3:30 p.m.
|
Content From ASCO - Gastrointestinal
CME: 0.75
|
|
3:30 p.m. – 4:15 p.m.
|
Content From ASCO - Leukemia
Speaker: Hayley McPhedran, PA-C, Physician Assistant, Inpatient Hematology, Vanderbilt University Medical Center
CME: 0.75
Review evidence based medicine updates from ASCO in the treatment of leukemia. Discuss limitations to data in the treatment of leukemia patients. Review the current standard of care in the management of leukemia.
|
|
CONCURRENT SESSION
4:15 p.m. – 5:00 p.m.
|
Heme Updates
CME: 0.75
|
|
CONCURRENT SESSION
4:15 p.m. – 5:00 p.m.
|
New Drug Approvals for Solid Tumors
Speaker: Kelly Plach, Clinical Pharmacy Specialist, Endeavor Health
CME: 0.75
This session will review recent approvals of new medications indicated for solid tumor disease states. The review will focus on the clinical efficacy, side effect profile, mechanism of action, and dosing considerations for these new agents.
|
|
5:00 p.m. – 5:05 p.m.
|
Closing Announcements
|
|
5:15 p.m. – 6:15 p.m.
|
Wine, Cheese, and Poster Presentations Reception
CME: 1.00
BACK TO TOP
|
Saturday, August 31, 2024
|
|
7:30 a.m. – 8:30 a.m.
|
Non-CME Product Theater Breakfast
|
|
8:35 a.m. – 9:40 a.m.
|
Welcome Announcements and General Session
CME: 1.00
|
|
CONCURRENT SESSION
9:45 a.m. – 10:30 a.m.
|
Empowering Cancer Patients Through Lifestyle Medicine: An Innovative Approach to Wellness
Speaker: Amber Orman, MD, DipABLM, Radiation Oncology, AdventHealth
CME: 0.75
Learn how the 6 pillars of lifestyle medicine apply to cancer survivorship to both reduce risk of recurrence and improve other comorbidities.
|
|
CONCURRENT SESSION
9:45 a.m. – 10:30 a.m.
|
Pediatric ITP: A-Cute Disease
Speaker: Rachel La Costa, PA-C, DMSc, Physician Assistant, Pediatric Hematology/Oncology and Stem Cell Transplant
CME: 0.75
Immune thrombocytopenia (ITP) in children often presents differently than in adults. This session will highlight the unique features of pediatric ITP, including presentation, diagnosis, and therapeutic recommendations from the American Society of Hematology (ASH).
|
|
10:35 a.m. – 10:50 a.m.
|
Refreshment Break
|
|
CONCURRENT SESSION
10:55 a.m. – 11:40 a.m.
|
HCC and Implication of Fatty Liver Disease
CME: 0.75
|
|
CONCURRENT SESSION
10:55 a.m. – 11:40 a.m.
|
Peds
CME: 0.75
|
|
11:45 a.m. – 12:55 p.m.
|
Pediatric Oncology: A Need for Lifelong Care
Speakers: Derek Tsang, MD, MSc, Radiation Oncologist, Princess Margaret Cancer Centre and Elizabeth Burghen, PPCNP-BC, Pediatric Nurse Practitioner, St. Jude Children's Research Hospital
CME: 1.00
In this session, Ms. Elizabeth Burghen (St. Jude Children's Research Hospital) and Dr Derek Tsang (Princess Margaret Cancer Centre) will be hosting an interactive lecture on long-term side effects of childhood cancer treatment. Using three case examples, attendees will be asked about their knowledge of therapeutic toxicities post-treatment. The lecture will then guide attendees through a discussion regarding specific side effects applicable to common systemic therapies and radiation therapy, and ways to monitor and mitigate these toxicities at the time of treatment decision-making and into survivorship care.
|
|
1:00 p.m. – 2:00 p.m.
|
Non-CME Product Theater Lunch
|
|
CONCURRENT SESSION
2:05 p.m. – 2:50 p.m.
|
EQ: Your RX to Better Patient Care
Speaker: Risa Zimmerman, PA-C, Director, Office of Advanced Practice, Nebraska Medicine
CME: 0.75
Learning how to understand your own emotional quotient is an important part of being a provider. This presentation will showcase how to exercise EQ and provide better care for your patients.
|
|
CONCURRENT SESSION
2:05 p.m. – 2:50 p.m.
|
That's Going to Need More Than a Band-Aid
Speaker: Lauren Imboden, PA-C, Adult Classical Hematology, Pediatric & Adult Hemophilia PA and HTC Coordinator, Atrium Wake Forest Baptist
CME: 0.75
Take some time to review the coagulation cascade and increase your knowledge of a variety of bleeding disorders.
|
|
CONCURRENT SESSION
2:55 p.m. – 3:40 p.m.
|
Common Benign Hematology Consult Questions
Speaker: Jennifer Dahl, PA-C, Physician Assistant, M Health Fairview
CME: 0.75
Review the pathophysiology, differential diagnoses, initial work-up and management of common inpatient hematology conditions such as cytopenias and thromboses.
|
|
CONCURRENT SESSION
2:55 p.m. – 3:40 p.m.
|
Targeted Therapies for AML
CME: 0.75
|
|
3:45 p.m. – 3:50 p.m.
|
Closing Announcements
|
|
CONCURRENT WORKSHOP
3:55 p.m. – 4:55 p.m.
|
Bone Marrow Workshop - Free to attend, but you must sign up.
Workshop Presenters: Jeremy Heinerich and Dwight Macero
CME: 1.00
|
|
CONCURRENT WORKSHOP
3:55 p.m. – 4:55 p.m.
|
Workshop TBD - Free to attend, but you must sign up.
CME: 1.00
BACK TO TOP
|
Sunday, September 1, 2024
|
|
7:45 a.m. – 8:10 a.m.
|
Breakfast
|
|
8:10 a.m. – 9:05 a.m.
|
Welcome Announcements and Harmony of Hope: How We Can All Hold Space For Patients
Speaker: Tracey Piparo, PA-C, DFAAPA, Palliative Medicine PA, RWJBarnabas
CME: 0.75
According to NHPC 2020 Palliative Care Needs survey, there were over 89,609 seriously ill individuals served in 2019 and one of the biggest challenges noted by palliative providers is referring providers and patients/families not having an understanding of palliative care. It is estimated that approximately 70-80% of cancer patients could benefit from palliative care services at some point during their illness trajectory (Ferrell et al., 2019). With the increasing recognition of the importance of early integration of palliative care in oncology, the potential patient population that would benefit from interdisciplinary care between Palliative and Oncology PAs is substantial. By working together, we can ensure that all oncology patients receive comprehensive, patient-centered care that addresses their unique needs while providing numerous advantages including improved quality of life, enhanced symptom management, better communication and decision-making, reduced healthcare utilization, and, in some cases, prolonged survival.
|
|
9:05 a.m. – 9:50 a.m.
|
MRSA In Oncology
CME: 0.75
|
|
9:50 a.m. – 10:35 a.m.
|
Management of Oncology Infusion Reactions
Speaker: Sarah Murawski, PA-C, Hematology/Oncology PA, Vanderbilt Ingram Cancer Center
CME: 0.75
This presentation will cover the management of common ipnatient and outpatient infusion reactions. It will also cover management of delayed reactions you may see in your clinic.
|
|
10:40 a.m. – 12:00 p.m.
|
Resume, Cover Letter, and CV Workshop
CME: 1.25
|
|
12:05 p.m. – 12:10 p.m.
|
Closing Announcements
|
